Non-Electric Biopsy Forceps

FDA 510(k) K900065 · Esco Precision, Inc.

Substantially Equivalent

510(k) numberK900065

Submission

Device name
Non-Electric Biopsy Forceps
Applicant
Esco Precision, Inc.
Stony Brook, NY, US
Received
January 4, 1990
Decision date
March 15, 1990
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
FCL – Forceps, Biopsy, Non-Electric
Device class
Class I (low risk)
Regulation
21 CFR 876.1075
Specialty
Gastroenterology, Urology

Other 510(k)s with product code FCL

510(k)DeviceApplicantDecision
K032092Olympus XCYF-TP3 Cystofiberscope/NephrofiberscopeFCL · Traditional Olympus Optical Co., Ltd.07/16/2003SE
K973611Spectrascience Reusable Biopsy ForcepsFCL · Traditional Spectrascience, Inc.12/02/1997SE
K971315Auxiliary Instruments for UrsFCL · Traditional Richard Wolf Medical Instruments Corp.09/15/1997SE
K964120Injecto FlushFCL · Traditional Robert J. Jynch, Jr.12/30/1996SE
K963517Spectra Science Biopsy ForcepsFCL · Traditional Spectrascience, Inc.12/02/1996SE
K955065Olympus FB Series Biopsy ForcepsFCL · Traditional Olympus America, Inc.01/24/1996SE
K952863Forceps, Biopsy, Non-ElectricFCL · Traditional Annex Medical, Inc.07/19/1995SE
K952391Dynabite Urological ForcepsFCL · Traditional Portlyn Corp.06/01/1995SE
K951048Rite-Bite Biopsy ForcepsFCL · Traditional Mill-Rose Laboratory03/15/1995SE
K946360Modular Biopsy ForcepFCL · Traditional Cox Medical Ent., Inc.03/06/1995SE

More from Cox Medical Ent., Inc.

510(k)DeviceDecision
K905088Hot Biopsy ForcepsKGE · Traditional 03/19/1991SE
K900015Non-Electric Biopsy ForcepsFCL · Traditional 03/15/1990SE

Questions and answers

When was Non-Electric Biopsy Forceps cleared by the FDA?

Non-Electric Biopsy Forceps (K900065) received a 510(k) decision of Substantially Equivalent on March 15, 1990, 70 days after the submission was received.

What is the product code of K900065?

The FDA product code is FCL – Forceps, Biopsy, Non-Electric, a Class I (low risk) device regulated under 21 CFR 876.1075.